Status:
COMPLETED
A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
A study comparing the early withdrawal of steroids to long-term maintenance steroid therapy in Kidney Transplant Patients receiving Prograf and Cellcept
Eligibility Criteria
Inclusion
- Inclusion:
- Patient is between post kidney transplant day 3-7 and no requirement for dialysis
- Exclusion:
- Patient is receiving kidney from HLA identical,living donor
- Patient is a multi-organ transplant recipient
- Patient is pregnant or lactating. Female patients of child bering potential must have a negative pregnancy test and agree to practice effective birth control
Exclusion
Key Trial Info
Start Date :
November 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
397 Patients enrolled
Trial Details
Trial ID
NCT00650468
Start Date
November 1 1999
End Date
December 1 2007
Last Update
November 17 2011
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Little Rock, Arkansas, United States, 72205
2
Loma Linda, California, United States, 92354
3
Los Angeles, California, United States, 90057
4
Denver, Colorado, United States, 80262